|
(ÁÖ)Çʷνýº |
Çʷνýº Meter »ý»ê¾÷ü ¿ÜÁÖ°ü¸® ´ã´çÁ÷¿ø ä¿ë
ÀüºÏ ±º»ê½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
»ý»ê/»ý»ê°ü¸® |
3³â¡è |
ä¿ë½Ã |
05.13 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] e-marketing manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
6³â¡è |
ä¿ë½Ã |
03.24 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] MR For Dupixient (Busan)
ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
11.25 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Insulin Junior Product Manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
08.06 |
|
|
Á¦Àϸ޵ñ½º¾àÇ° |
[¼¿ï]´ëÇÐ&Á¾ÇÕº´¿ø Á¦¾à¿µ¾÷ºÎ ÃÑ°ýÃ¥ÀÓÀÚ¸ðÁý
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
10³â¡è |
ä¿ë½Ã |
02.08 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
[Çѱ¹MSD]Business practice officer(Compliance officer)
¼¿ï Áß±¸, ¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
2³â¡è |
ä¿ë½Ã |
05.10 |
|
|
Á¦À̾¾¸ÞµðÆÊ |
Á¤Çü¿Ü°ú ¿µ¾÷ °æ·Â»ç¿ø ¸ðÁý
°æ±â ºÎõ½Ã ¿ø¹Ì±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
07.19 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Quality Associate
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
3³â¡è |
ä¿ë½Ã |
02.17 |
|
|
À̽ºÅÛ¸ÞµðÄ® |
RA QA ¸¶ÄÉÆà ¸ðÁýÇÕ´Ï´Ù
°æ±â ±¸¸®½Ã | ´ëÇÐ(2~3³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
2³â¡è |
ä¿ë½Ã |
07.23 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Medical Representative
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
12.10 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Field medical, Dupilumab (Medical manage
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
11.08 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
±¸¸ÅºÎ Procurement specialist ¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
3³â¡è |
ä¿ë½Ã |
11.08 |
|
|
ÀÌ¿ÀÇ÷οì ÁÖ½Äȸ»ç |
[ÀÌ¿ÀÇ÷οì] HW°³¹ß ´ã´çÀÚ Ã¤¿ë(´ë¸®±Þ)
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
04.18 |
|
|
½á¸ðÇǼŻçÀ̾ðƼÇÈ ÄÚ¸®¾Æ |
Operations Technician, Clinical Trials
¼¿ï °¼±¸ | °íµîÇб³ |
»ó¹Ý±â »ç¿ø¸ðÁý |
3³â¡è |
ä¿ë½Ã |
03.29 |
|
|
¾ÆÀÌÅ¥¾î(ÁÖ) |
ÇØ¿ÜRA °æ·ÂÁ÷ ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
3³â¡è |
ä¿ë½Ã |
04.16 |
|